ESC 365 - Reasons for a sequential treatment strategy in dyslipidemia.

Open Access

Reasons for a sequential treatment strategy in dyslipidemia.

Session: Sequential treatment strategy in dyslipidemia vs earlier use of combination therapies: decision-making factors

Topic: Lipids

Speaker: Professor E. Liberopoulos (Athens, GR)

Sponsored by SERVIER

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Professor Evangelos Liberopoulos

National & Kapodistrian University of Athens, Athens (Greece)

2 presentations

0 follower

3 more presentations in this session

Introduction.

Speaker: Professor A. Zambon (Padua, IT)

Should we encourage earlier and broader use of combination therapies in dyslipidemia?

Speaker: Professor F. Schiele (Besancon, FR)

Discussion.

Access the full session

Sequential treatment strategy in dyslipidemia vs earlier use of combination therapies: decision-making factors

Speakers: Professor E. Liberopoulos, Professor A. Zambon, Professor F. Schiele

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources